NEW DELHI -- India has opened another investigation into cough syrup in response to Uzbekistan's claim that 18 children died after consuming an Indian drugmaker's product, nearly three months after a similar controversy in Gambia.
Allegations echo Gambia scandal, casting new doubts on 'pharmacy of the world'
Police officers are seen outside a Marion Biotech office in Noida, India, on Dec. 29. Uzbekistan says 18 children died after consuming the company's cough syrup. © Reuters
NEW DELHI -- India has opened another investigation into cough syrup in response to Uzbekistan's claim that 18 children died after consuming an Indian drugmaker's product, nearly three months after a similar controversy in Gambia.